
HOUSTON, March 10, 2022 (FibroBiologics PR) – FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, today announced the addition of Kathleen “Kate” Rubins, Ph.D., to its Scientific Advisory Board (SAB). A microbiologist and NASA astronaut, Dr. Rubins has conducted pioneering medical research on viruses at high-profile academic institutions as well as on board the International Space Station (ISS). She holds a B.S. in Molecular Biology from the University of California and Ph.D. in Cancer Biology from Stanford University.
(more…)